Recently highlighted nutraceuticals for preventive management of osteoarthritis

被引:29
作者
Ravalli, Silvia [1 ]
Szychlinska, Marta Anna [1 ]
Leonardi, Rosalia Maria [2 ]
Musumeci, Giuseppe [1 ]
机构
[1] Univ Catania, Sch Med, Human Anat & Histol Sect, Dept Biomed & Biotechnol Sci, Via S Sofia 87, I-95123 Catania, Italy
[2] Univ Catania, Dept Orthodont, Policlin Univ Vittorio Emanuele, I-95124 Catania, Italy
关键词
Osteoarthritis; Nutraceuticals; Prevention; Diet; Inflammation; Oxidative stress;
D O I
10.5312/wjo.v9.i11.255
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Osteoarthritis (OA) is a chronic degenerative disease of articular cartilage with limited treatment options. This reality encourages clinicians to suggest preventive measures to delay and contain the outbreak of the pathological conditions. Articular cartilage and synovium suffering from OA are characterised by an inflammatory state and by significant oxidative stress, responsible for pain, swelling and loss of mobility in the advanced stages. This review will focus on the ability of olive oil to exert positive effects on the entire joint to reduce pro-inflammatory cytokine release and increase lubricin synthesis, olive leaf extract, since it maintains lubrication by stimulating high molecular weight hyaluronan synthesis in synovial cells, curcumin, which delays the start of pathological cartilage breakdown, sanguinarine, which downregulates catabolic proteases, vitamin D for its capacity to influence the oxidative and pro-inflammatory environment, and carnosic acid as an inducer of heme oxygenase-1, which helps preserve cartilage degeneration. These molecules, considered as natural dietary supplements, appear like a cutting-edge answer to this tough health problem, playing a major role in controlling homeostatic balance loss and slowing down the pathology progression. Natural or food-derived molecules that are able to exert potential therapeutic effects are known as "nutraceutical", resulting from the combination of the words "nutrition" and "pharmaceutical". These compounds have gained popularity due to their easy availability, which represents a huge advantage for food and pharmaceutical industries. In addition, the chronic nature of OA implies the use of pharmacological compounds with proven long-term safety, especially because current treatments like nonsteroidal anti-inflammatory drugs and analgesics improve pain relief but have no effect on degenerative progression and can also cause serious side effects.
引用
收藏
页码:255 / 261
页数:7
相关论文
共 50 条
[1]
Nitric oxide in inflammation and pain associated with osteoarthritis [J].
Abramson, Steven B. .
ARTHRITIS RESEARCH & THERAPY, 2008, 10 (Suppl 2)
[2]
Current nutraceuticals in the management of osteoarthritis: a review [J].
Akhtar, Nahid ;
Haqqi, Tariq M. .
THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2012, 4 (03) :181-207
[3]
Relevance of carnosic acid to the treatment of several health disorders: Molecular targets and mechanisms [J].
Bahri, Sana ;
Jameleddine, Saloua ;
Shlyonsky, Vadim .
BIOMEDICINE & PHARMACOTHERAPY, 2016, 84 :569-582
[4]
Bone remodelling in osteoarthritis [J].
Burr, David B. ;
Gallant, Maxime A. .
NATURE REVIEWS RHEUMATOLOGY, 2012, 8 (11) :665-673
[5]
Subchondral bone as a key target for osteoarthritis treatment [J].
Castaneda, Santos ;
Roman-Blas, Jorge A. ;
Largo, Raquel ;
Herrero-Beaumont, Gabriel .
BIOCHEMICAL PHARMACOLOGY, 2012, 83 (03) :315-323
[6]
Nutraceutical Supplements in the Management and Prevention of Osteoarthritis [J].
Castrogiovanni, Paola ;
Trovato, Francesca Maria ;
Loreto, Carla ;
Nsir, Houda ;
Szychlinska, Marta Anna ;
Musumeci, Giuseppe .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (12)
[7]
Sp1 and Sp3 transcription factors mediate interleukin-1β down-regulation of human type II collagen gene expression in articular chondrocytes [J].
Chadjichristos, C ;
Ghayor, C ;
Kypriotou, M ;
Martin, G ;
Renard, E ;
Ala-Kokko, L ;
Suske, G ;
de Crombrugghe, B ;
Pujol, JP ;
Galéra, P .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (41) :39762-39772
[8]
Pharmaceutical Therapy for Osteoarthritis [J].
Cheng, David S. ;
Visco, Christopher J. .
PM&R, 2012, 4 (05) :S82-S88
[9]
Dervendzi V., 1992, CONT TREATMENT MED P, P5
[10]
Chondroprotective effects of high-molecular-weight cross-linked hyaluronic acid in a rabbit knee osteoarthritis model [J].
Elmorsy, S. ;
Funakoshi, T. ;
Sasazawa, F. ;
Todoh, M. ;
Tadano, S. ;
Iwasaki, N. .
OSTEOARTHRITIS AND CARTILAGE, 2014, 22 (01) :121-127